KalVista Pharmaceuticals

creating a new generation of small molecule protease inhibitors for HAE and DME

KalVista Pharmaceuticals Appoints Nancy Stuart to Board of Directors

KalVista Pharmaceuticals Reports Third Fiscal Quarter Results

KalVista Pharmaceuticals to Present at SVB Leerink Global Healthcare Conference